News und Analysen
2 Dividend Stocks That Doubled Their Payouts in 5 Years
Dividend stocks can be worth investing in, even if they don't offer big yields. That's particularly the case when it comes to companies that regularly raise their payouts. Although your initial
Why UnitedHealth Stock Shot Higher on Tuesday
Big insurer UnitedHealth (NYSE: UNH) was the very picture of health, at least as far as its stock was concerned on Tuesday. Its price rose by a sprightly 3.3% that day, well eclipsing the 0.7% rise
Why Shares of Masimo Are Dropping Tuesday
Shares of Masimo (NASDAQ: MASI) were down by 18.5% as of 1:30 p.m. on Tuesday. The patient monitoring company announced preliminary numbers for the second quarter after the markets closed on Monday
Should You Buy This Dividend-Growth Machine for Your Portfolio?
For a dividend-growth investor, the path to lasting success is as simple as buying and holding businesses that are consistently growing. After all, steadily rising profits drive dividend growth over
The Retirement Mistake That Costs 4 in 10 People Thousands of Dollars
Employer-sponsored retirement plans like the 401(k) are the primary tool working people use to save for their golden years. People used to spend all or most of their working years with one company
Should You Buy the Dip With Biogen Stock Right Now?
With shares of Biogen (NASDAQ: BIIB) falling by 11% in the last 30 days, and by 20% in the last five years, could there be an opportunity for enterprising investors to buy the dip on this struggling
2 Monster Stocks to Buy Without Any Hesitation
Everyone's portfolio should include a couple of monster stocks. What do I mean by "monster"? I'm talking about companies that have a solid earnings track record and offer bright prospects down the
These 2 Numbers Should Scare Every Biogen Shareholder
Most Biogen (NASDAQ: BIIB) shareholders are probably excited about the company's newly approved Alzheimer's drug Leqembi right about now, and it's no surprise why. Some commentators are calling for
3 Dividend Growth Stocks to Buy and Hold
Wayne Gretzky probably had no idea how much one thing he said would be repeated through the years. But one of his most famous statements certainly was memorable and worthy of repetition: "I skate to
7 Spectacular High-Yield Dividend Stocks to Buy in July
You don't have to settle for puny dividend income. Thousands of stocks offer dividends. Many of them, though, have dividend yields that don't amount to a hill of beans.
What if you could invest in
UnitedHealth Group (UNH) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
UnitedHealth Group (NYSE: UNH)Q2 2023 Earnings CallJul 14, 2023, 8:45 a.m. ET
Operator
Source Fool.com
Why Shares of UnitedHealth Group Are Up Friday
Shares of UnitedHealth Group (NYSE: UNH), the nation's largest private medical insurer, were up more than 6.6% as of 11 a.m. ET on Friday after the company reported second-quarter earnings. The heal
2 Biotech Stocks That Could Make You Richer
When looking for stocks that can make one richer, investors often start with names they know. The problem is that the names they know also tend to be the names that everyone knows, and these stocks
Vertex Pharmaceuticals: Buy at the High?
Vertex Pharmaceuticals (NASDAQ: VRTX) has climbed nearly 20% so far this year. And that leaves the stock trading a few dollars off its record high. It's not surprising Vertex has advanced. The
Why Novavax Stock Tumbled 28% in the First Half of 2023
Shares of Novavax (NASDAQ: NVAX) lost 28% of their value in the first six months of the year, according to data from S&P Global Market Intelligence, extending a downtrend that began in early 2022
Why Shares of GoodRx Holdings Climbed This Week
Share of GoodRx Holdings (NASDAQ: GDRX) rose more than 32% for the week, as of Thursday at 2:15 p.m. ET, according to data provided by S&P Global Market Intelligence. The healthcare stock is up more
Is Amgen's Dividend Safe?
Amgen (NASDAQ: AMGN) is a global leader in biotechnology, with a market capitalization of over $121 billion. The company has a proven track record of developing breakthrough therapies for
2 Top Healthcare Stocks to Buy Right Now
When you invest in industries that are positioned to capitalize on secular trends, owning wonderful businesses for the long haul is all it takes to build wealth and passive income. As the world's
2 No-Brainer Healthcare Stocks to Buy With $100 Right Now
Investing $100 can be a good amount to get started in stocks, especially if you're using a brokerage that charges low commission fees or none at all. And over time, you can steadily grow your
Why Isn't Biogen Stock Soaring After This Major FDA Approval?
Investors in Biogen (NASDAQ: BIIB) got some great news last week as the Food and Drug Administration (FDA) approved the company's Alzheimer's drug Leqembi. But despite the big win, the stock didn't
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
Make money. That's every investor's goal. How each person chooses to achieve that goal makes the difference in exactly how much money they make and how long it takes to make it.
Some stocks are
2 Hot Stocks Up 30% This Year That Wall Street Thinks Can Still Go Higher
The S&P 500 is up 15% this year, and there are many stocks that have been performing much better than that. Shares of Hims & Hers Health (NYSE: HIMS) and Viking Therapeutics (NASDAQ: VKTX) have been
Where to Invest $5,000 for the Next 10 Years
Did you know that if you earned an average of 7% per year, your investment would double in 10 years? That's lower than the S&P 500's long-run average of 10%. Investing in some top growth stocks
3 Things About Vertex Pharmaceuticals That Smart Investors Know
Vertex Pharmaceuticals' (NASDAQ: VRTX) stock has climbed nearly 20% so far this year, and for good reason. The biotech company completed a regulatory submission for what may become its next
Is This a Good Sign for Novavax?
Novavax (NASDAQ: NVAX) shares soared more than 30% in one trading session this week. That's a huge gain for any stock. But it's particularly impressive for Novavax. The biotech stock has been in the